|
Positive Phase II Asthma Clinical Trial Data
SYS-CON Media (press release) This pioneering trial investigated the potential for SNG001 (inhaled interferon beta) to protect asthmatics from respiratory virus infections (principally the common cold) that can spread to the lung, which are a major cause of worsening asthma … |
View full post on asthma – Google News